ATTENTIA
A new approach to psychodiagnostics
Clarity over stigma, access over privilege. Care should be fair, not a marathon. Attentia is a kinder path to ADHD answers where more people are seen, heard and helped.
Make ADHD measurable
ADHD assessment today is slow, expensive and uneven. These are the gaps we are designing against.
The problem today
Access, bias and affordability
of adults with ADHD remain undiagnosed or untreated1
typical wait times for an ADHD assessment2
for women to receive diagnosis despite similar symptom severity3
typical out of pocket cost for private assessment4
The human cost
Outcomes of untreated ADHD
reduced life expectancy for untreated adults5
higher mortality, mainly preventable accidents and suicide6
in mortality with early diagnosis and treatment7
Objective, fast and affordable ADHD assessment
Attentia combines gaze, speech and task data into one structured assessment that supports, not replaces, clinical judgment.
Our solution
per assessment, typically €350–€400 less than private routes
results in days, not months
complete at home or in clinic
speech, eye tracking, behavioural tasks and dialogue
Built for clinicians
Decision support with clear next steps
concise report with likelihood bands and key evidence
top contributing signals surfaced for transparency
you make the diagnosis, we provide objective metrics
designed for GDPR and MDR pathways and EHR or insurer export
Co designed with ADHD specialists
Built from ADHD research and iterative feedback from clinicians who diagnose ADHD every day, Attentia summary pages surface what matters most: diagnostic impression, objective metrics and the key evidence behind them.
Asura
Digital ADHD Assessment · Summary report (page 1)
Patient: Jane Doe
Patient ID: 1842-A3
Assessment date: 12 Jan 2026
Report version: v0.9
Asura model: v0.9
Diagnostic impression (decision-support)
Clinically significant ADHD (ICD-10 F90.2 – hyperkinetic disorder, combined presentation)
Decision-support probability: 0.89 (95% interval 0.82–0.93)
Thresholds: ≥0.75 high likelihood · 0.55–0.74 borderline · <0.55 low likelihood.
Key supporting factors
- Symptom pattern: Inattention 7/9; hyperactivity / impulsivity 6/9, above threshold for ICD-10 F90 hyperkinetic disorder.
- Course & context: Symptoms present since primary school, persistent > 6 months, with impact at home and in work/education.
- Functional impact: Moderate impairment in work performance, deadlines, organisation and daily functioning.
- Multimodal evidence: Convergent findings from structured interview, collateral report and objective metrics (attention, inhibition, motor activity, gaze).
Overall profile is most consistent with ADHD as the primary diagnosis. Final diagnosis remains at the discretion of the treating clinician.
Profile validity: Adequate
Embedded effort and consistency indices within normal limits. No evidence of non-credible responding.
Objective scores & norms
Eye-tracking, speech, interview and attention-task metrics are reported as age-adjusted percentiles vs a non-clinical reference sample (50th = average; ≥90th = marked elevation in an ADHD-consistent direction). Full scoring details are available on subsequent pages.
- • Findings support ADHD, combined presentation (ICD-10 F90.2 – hyperkinetic disorder, combined type) as the primary diagnosis.
- • Symptom counts, onset in childhood, duration and cross-situational impairment meet criteria for F90 hyperkinetic disorder.
- • Objective measures in attention, inhibition, motor activity and gaze deviate substantially from norms in an ADHD-consistent direction.
- • No single alternative condition better explains the overall pattern; comorbidities, if present, are documented separately.